Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

XSense™ system's innovative cryogenic connector technology designed to improve safety and maintain the integrity of cryogen used in the cryoablation procedure CAESAREA, Israel, Jan. 3 ...

Background: Cryoablation (CRYO) is an alternative to radiofrequency (RF) ablation in the treatment of atrioventricular nodal reentrant tachycardia (AVNRT). This study aims to evaluate the ...

Just kidding, all you need to do is click your mouse, and your avatar will do all the walking in the Maze Simulator. You can never be entirely sure you’ve typed in a code correctly if you’re ...

The use of cryoablation for postsurgical pain reduced hospital length of stay, hospital costs, and postoperative opioid use among patients who underwent lobectomy for lung cancer. Intercostal ...

Caesarea, Israel-based IceCure designed it to work as part of its XSense cryoablation system. The connector aims to improve safety and maintain the integrity of cryogen used in the cryoablation ...

Ants and humans competed in navigating a maze with a large load. While humans outperformed individually, ant groups excelled collectively, showing strategic coordination and persistence. The study ...